Riskpilot← Back to searchSign inGet full accessLäkarleasing Syd AB
ABActiveOrg 5569745010Björketvägen 2General medical practice activities · NACE 8621Est. 20141 employees
Revenue 2024
SEK 786K
+3% vs 2023
EBITDA margin
17.6%
-79% vs 2023
Equity ratio
51.2%
Financial strength
Net profit 2024
SEK 198K
-62% vs 2023
| Revenue | SEK 786K | +3% |
| EBITDA | SEK 139K | -79% |
| Net profit | SEK 198K | -62% |
| Total assets | SEK 1,6M | -9% |
| Equity | SEK 839K | -1% |
| Employees | 1 | — |
Legal name
Läkarleasing Syd AB
Org number
5569745010
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 juni 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver rekrytering och uthyrning av personal inom vård och omsorg samt därmed förenlig verksamhet. Äga och förvalta fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Björketvägen 2
Email
esthermillar1976@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 352 | 290 | 167 | 766 | 786 |
| Staff expenses | — | — | — | −5 | −606 |
| EBITDA | 266 | 211 | 96 | 662 | 139 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 266 | 211 | 96 | 662 | 139 |
| Net financials | 9 | 9 | 0 | 2 | 0 |
| Profit before tax | 205 | 165 | 97 | 654 | 258 |
| Tax | −45 | −35 | −11 | −137 | −59 |
| Net profit | 160 | 130 | 86 | 516 | 198 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 439 | 1 559 | 1 274 | 1 809 | 1 640 |
| Equity | 645 | 775 | 524 | 845 | 839 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 141 | 75 | 42 | 246 | 201 |
| Total debt | 141 | 75 | 42 | 246 | 201 |
EBITDA margin
17.6%
This company
15.8%
Market median
+11% vs market
20202024
Equity ratio
51.2%
This company
38.2%
Market median
+34% vs market
20202024
Return on equity
23.6%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
25.2%
This company
8.1%
Market median
+211% vs market
20202024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20202024
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkarleasing Syd AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Esther Ruth Millar | Board of Directors | 0 companies |
| Scott Alexander Millar | Deputy Board Member | 0 companies |
| Elias Simon Sperlich | Deputy Board Member | 0 companies |